Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 1	$ 1
Other accounts receivable and prepaid expenses	6	10
Total current assets	7	11
TOTAL ASSETS	7	11
Current Liabilities
Accrued expenses and other payables	307	246
Short Term Loans	30	0
Related Parties	166	110
Total current liabilities	503	356
Long term Liabilities
Related Parties	0	0
Total Liabilities	503	356
Shareholders' deficiency
Common stock, $0.01 par value – Authorized: 51,000,000; issued and outstanding: 5,153,461 as of December 31, 2021 and 2020	52	52
Additional paid in capital	1,937	1,921
Accumulated deficit	(2,485)	(2,318)
Total stockholders' deficiency	(496)	(345)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 7	$ 11

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.